RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..3 of 3 - per page
Order by
PsoriaVa™ (Pre-IND- Calcipotriene 0.005%/Betamethasone 0.64%, Psoriasis)
PsoriaVaTM incorporates calcipotriene 0.005%/betamethasone 0.64%) and the NexACT® technology. Pre-clinical studies have shown PsoriaVA® to deliver the same level of drugs as Taclonex with indication of superior safety profile. More
Single Round PCR Assay to Detect Low Copy HIV-1 in Filter Paper Blood Spots
Single Round PCR Assay to Detect Low Copy HIV-1 in Filter Paper Blood Spots More
Methods for Diagnosing and Treating Disease Associated with CMG-2 Deficiency
Methods for Diagnosing and Treating Disease Associated with CMG-2 Deficiency More
Displaying 1..3 of 3 - per page
Order by

Related Reports

Market Research Reports provided by reports.innovaro.com
The National Institute of Allergy and Infectious Diseases – Developmental Therapeutics Review – Q4 2010
Nov 2010 - 40 pages - $500
Allergy Therapy Area Pipeline Report
Nov 2010 - 1517 pages - $1,495
Grass Pollen Allergy - Pipeline Review, Q2 2011
May 2011 - 34 pages - $500
Allergy Therapeutics plc (AGY) - Financial and Strategic SWOT Analysis Review
May 2011 - 35 pages - $125
Allergy Therapeutics plc – Product Pipeline Review – Q4 2010
Dec 2010 - 48 pages - $500
Birch Pollen Allergy - Pipeline Review, Q2 2011
May 2011 - 39 pages - $500
Allergy Therapeutics plc (AGY) - Financial and Strategic SWOT Analysis Review
Feb 2011 - 28 pages - $125
Enjoy Life Natural Brands Case Study: capitalizing on rising consumer interest in anti-allergy foods
Aug 2009 - 11 pages - $295
ALK-Abello AS - SWOT Analysis
Nov 2010 - 22 pages - $125
Allergy Research Group, Inc.-Detailed Product Pipeline
Jul 2010 - 180 pages - $750
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2012 Innovaro Europe Ltd Innovaro Corporation All rights reserved. Terms and Conditions | Contact us